Core Laboratories Stock Financials

CLB
 Stock
  

USD 13.48  0.71  5.00%   

You can use fundamental analysis to find out if Core Laboratories is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate thirty-eight available fundamental indicators for Core Laboratories NV, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Core Laboratories financials, including its number of shares shorted, revenue, cash and equivalents, as well as the relationship between the price to book and ebitda . Given that Core Laboratories has a price to earning of 32.88 X, we suggest you to validate Core Laboratories NV prevailing market performance to make sure the company can sustain itself down the road. Use Core Laboratories to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Core Laboratories to be traded at $12.81 in 90 days.
  
With this module, you can analyze Core Laboratories financials for your investing period. You should be able to track the changes in Core Laboratories individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Core Laboratories Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Core Laboratories' financial statements are interrelated, with each one affecting the others. For example, an increase in Core Laboratories' assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 49
Core Laboratories NV has less than 49 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Core Laboratories stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Core Laboratories' official financial statements usually reflect Core Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Core Laboratories. For example, before you start analyzing numbers published by Core Laboratories accountants, it's critical to develop an understanding of what Core Laboratories' liquidity, profitability, and earnings quality are in the context of the Energy space in which it operates.
Please note, the presentation of Core Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Core Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Core Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Core Laboratories NV. Please utilize our Beneish M Score to check the likelihood of Core Laboratories' management to manipulate its earnings.

Core Laboratories Company Summary

Core Laboratories competes with Amazon. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States.
Foreign Associate  Netherlands
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
Business AddressVan Heuven Goedhartlaan
SectorEnergy
IndustryOil & Gas Equipment & Services
BenchmarkDOW
Websitewww.corelab.com
Phone31 20 420 3191
CurrencyUSD - US Dollar
You should never invest in Core Laboratories without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Core Laboratories Stock, because this is throwing your money away. Analyzing the key information contained in Core Laboratories' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Core Laboratories Key Financial Ratios

Generally speaking, Core Laboratories' financial ratios allow both analysts and investors to convert raw data from Core Laboratories' financial statements into concise, actionable information that can be used to evaluate the performance of Core Laboratories over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Core Laboratories reports annually and quarterly.

Core Laboratories Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Core Laboratories's current stock value. Our valuation model uses many indicators to compare Core Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Core Laboratories competition to find correlations between indicators driving Core Laboratories's intrinsic value. More Info.
Core Laboratories NV is number one stock in return on equity category among related companies. It is number one stock in gross profit category among related companies fabricating about  18,443,243  of Gross Profit per Return On Equity. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Core Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Core Laboratories' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Core Laboratories' earnings, one of the primary drivers of an investment's value.

Core Laboratories Systematic Risk

Core Laboratories' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Core Laboratories volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-one with a total number of output elements of thirty. The Beta measures systematic risk based on how returns on Core Laboratories correlated with the market. If Beta is less than 0 Core Laboratories generally moves in the opposite direction as compared to the market. If Core Laboratories Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Core Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Core Laboratories is generally in the same direction as the market. If Beta > 1 Core Laboratories moves generally in the same direction as, but more than the movement of the benchmark.
.

About Core Laboratories Financials

What exactly are Core Laboratories Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Core Laboratories' income statement, its balance sheet, and the statement of cash flows. Potential Core Laboratories investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Core Laboratories investors may use each financial statement separately, they are all related. The changes in Core Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Core Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Core Laboratories is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Core Laboratories has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Core Laboratories October 1, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Core Laboratories help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Core Laboratories NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Core Laboratories NV based on widely used predictive technical indicators. In general, we focus on analyzing Core Laboratories Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Core Laboratories's daily price indicators and compare them against related drivers.
Information Ratio(0.11)
Maximum Drawdown20.73
Value At Risk(6.33)
Potential Upside5.93
Continue to Trending Equities. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core Laboratories will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.